Therapy of mitochondrial disorders
- PMID: 3119936
- DOI: 10.1007/BF01812853
Therapy of mitochondrial disorders
Abstract
Mitochondrial disorders, namely defects of fatty acid oxidation, defects of pyruvate metabolism and defects of the respiratory chain are heterogenous in clinical picture and in response to therapeutic attempts. Defects of fatty acid metabolism are amenable to therapy by dietary means, carnitine substitution and in some cases with vitamins. Defects in pyruvate metabolism do not respond to therapy except in some special cases. Therapeutic attempts include dietary measures, vitamins as coenzyme precursors. Defects in the respiratory chain appear to respond to treatment only in exceptional cases. Evaluation of treatment effects appears to be singularly difficult. General measures that can be of benefit to different defects are discussed.
Similar articles
-
Genetic disorders of carnitine metabolism and their nutritional management.Annu Rev Nutr. 1998;18:179-206. doi: 10.1146/annurev.nutr.18.1.179. Annu Rev Nutr. 1998. PMID: 9706223 Review.
-
Mitochondrial myopathies.J Inherit Metab Dis. 1987;10 Suppl 1:113-28. doi: 10.1007/BF01812852. J Inherit Metab Dis. 1987. PMID: 2824920 Review.
-
Prospective treatment in carnitine-acylcarnitine translocase deficiency.J Inherit Metab Dis. 2007 Oct;30(5):815. doi: 10.1007/s10545-007-0518-x. Epub 2007 May 12. J Inherit Metab Dis. 2007. PMID: 17508264
-
Toxicity of cephaloridine to carnitine transport and fatty acid metabolism in rabbit renal cortical mitochondria: structure-activity relationships.J Pharmacol Exp Ther. 1994 Sep;270(3):873-80. J Pharmacol Exp Ther. 1994. PMID: 7932199
-
Disorders of mitochondrial long-chain fatty acid oxidation and the carnitine shuttle.Rev Endocr Metab Disord. 2018 Mar;19(1):93-106. doi: 10.1007/s11154-018-9448-1. Rev Endocr Metab Disord. 2018. PMID: 29926323 Free PMC article. Review.
Cited by
-
Cloning and characterization of murine carnitine acetyltransferase: evidence for a requirement during cell cycle progression.Biochem J. 1997 Mar 1;322 ( Pt 2)(Pt 2):403-10. doi: 10.1042/bj3220403. Biochem J. 1997. PMID: 9065756 Free PMC article.
-
Therapy of complex I deficiency: peripheral neuropathy during dichloroacetate therapy.Eur J Pediatr. 1995 Nov;154(11):928-32. doi: 10.1007/BF01957508. Eur J Pediatr. 1995. PMID: 8582409
-
Molecular defects of NADH-ubiquinone oxidoreductase (complex I) in mitochondrial diseases.J Bioenerg Biomembr. 1988 Jun;20(3):365-82. doi: 10.1007/BF00769638. J Bioenerg Biomembr. 1988. PMID: 3136150 Review.
-
A scientific rationale for protective therapy in Parkinson's disease.J Neural Transm Gen Sect. 1993;91(2-3):161-80. doi: 10.1007/BF01245230. J Neural Transm Gen Sect. 1993. PMID: 8512683 Review.
-
Mitochondrial disorders and the kidney.Arch Dis Child. 1998 Apr;78(4):387-90. doi: 10.1136/adc.78.4.387. Arch Dis Child. 1998. PMID: 9623410 Free PMC article. Review. No abstract available.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases